(Q33523148)
Statements
1 reference
A phase 1 study evaluating the pharmacokinetics, safety and tolerability of repeat dosing with a human IL-13 antibody (CAT-354) in subjects with asthma (English)
1 reference
Dave Singh
1 reference
Binita Kane
1 reference
Nestor A Molfino
1 reference
Raffaella Faggioni
1 reference
Lorin Roskos
1 reference
8 January 2010
1 reference
1 reference
10
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference
1 reference